MedPath

MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY

Recruiting
Conditions
Heart Failure
Registration Number
NCT05915364
Lead Sponsor
University of Catanzaro
Brief Summary

The MAGIC-HF STUDY project (MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure STUDY), is an observational prevalence and incidence study focusing on the role that risk factors, various comorbidities, and their treatment may have on CV and non-CV outcomes in patients with all forms of HF. It also aim to assess whether comorbidities and their treatment may be predictors of response to pharmacological and non-drug treatment of HF.

Detailed Description

Adult subjects with all forms of HF (HFrEF, HFmrEf, HEpEF) with at least one comorbidity who are referred to the Heart Failure Outpatient Clinic of the AOU "Mater Domini" Geriatrics Unit in Catanzaro will be recruited.

Initially, patients will be evaluated at baseline and followed-up for a minimum of six-month.

All patients will be subjected to clinical, instrumental and laboratory examinations, including medical history data collection and complete anthropometric assessment . Plasma and serum samples will be collected at recruitment and at the six-months follow-up visit. Stool samples will also be obtained and stored at -80C for the omics studies.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Informed Consent obtained before performing any procedure
  • Age>18 years old
  • Confirmed diagnosis of HFrEF, HFmrEF, HFpEF with clinical stability for at least 4 weeks
  • Presence of at least one of the following comorbidities:
  • Atrial fibrillation
  • Peripheral arteriopathy
  • Hypertension
  • Chronic ischemic heart disease
  • Diabetes mellitus type 2 or insulin resistance
  • Hepatopathy
  • Obesity
  • Cancer
  • Sleep apnea syndrome
  • Chronic kidney disease
  • Iron deficiency
  • Cognitive Decline or Depression
  • Sarcopenia
  • Dysthyroidisms
  • Hypovitaminosis D
  • Hyperuricemia
Exclusion Criteria
  • Liver cirrhosis Child-Pugh C
  • Severe chronic renal failure defined by an estimated glomerular filtration rate (eGFR) value < 15 ml/min/1.73 m2 according to CKD-EPI
  • Suspected alcohol or drug abuse
  • Pregnancy or breast feeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of cardiac parameters6 months

Echocardiographic evaluation of the left ventricular global system, left ventricular ejection fraction, left atrial diameter, cardiac output, cardiac index, right ventricular global function by Color-Doppler echocardiogram (Vivid E95, GE Healthcare, Horten, Norway)

Determination of intimal media thickness6 months

Determination of intimal media thickness by high-resolution ultrasonography of common carotid arteries

Spekle-tracking Imaging6 months

A 2D speckle tracking analysis was retrospectively performed using vendor-specific 2D speckle tracking software (EchoPAC PC, version 113.0.5, GE Healthcare, Horten, Norway). Manual tracings of the endocardial border during end-systole in three apical views was performed to evaluate GLS.

echocardiogram (Vivid E95, GE Healthcare, Horten, Norway)

Montreal Cognitive Assessment6 months

Geriatric multidimensional assessment for the evaluation of Montreal Cognitive Assessment (MoCA) in patients over 65 years old. This one-page 30-point test can be administered to the patient in at last 10 min. Cut-off score 26 points.

Evaluation of autonomy in daily activities6 months

Geriatric multidimensional assessment for the evaluation of autonomy in daily activities living (ADL) in patients over 65 years old. The score ranges from 0/6 (maximum dependence) to 6/6 (maximum autonomy).

MiniMental State examination6 months

Geriatric multidimensional assessment for the evaluation of MiniMental State examination (MMSE), in patients over 65 years old (range values 0-30 score).

Geriatric depression scale6 months

Geriatric multidimensional assessment for the evaluation of Geriatric depression scale (GDS) in patients over 65 years old. The short form (GDS-S) consists of 15 items. Of the 15 elements, 10 indicate the presence of depression when responding positively, while the other five are indicative of depression when responding negatively, moreover \> 5 points suggest depression and require follow-up evaluation, ≥ 10 points almost always indicates depression.

Autonomy in instrumental activities of daily living6 months

Geriatric multidimensional assessment for the evaluation of autonomy in instrumental activities of daily living (IADL) in patients over 65 years old. Range values 0-8 points.

Short Performance Physical battery6 months

Geriatric multidimensional assessment for the evaluation of Short Performance Physical battery (SPPB) in patients over 65 years old. The total score of the scale has a range from 0 to 12 minutes.

Assessment of endothelial function6 months

Evaluation of endothelial function by Digital semiplethysmographic method through EndoPAT

Sarcopenia6 months

Geriatric multidimensional assessment for the evaluation of Sarcopenia by SARC-f questionnaire in patients over 65 years old. Score Range 0-10 points.

Pulse Wave velocity assessment6 months

Evaluation of carotid-femoral pulse wave velocity by SphygmoCor

Determination of lipopolysaccharide6 months

Evaluation of lipopolysaccharide by ELISA sandwich

Secondary Outcome Measures
NameTimeMethod
Study of functional gut microbiota6 months

Evaluation of gut microbiota by omics methods

Evaluation of gut microbiota6 months

Evaluation of gut microbiota by bioinformatic methods

Evaluation of platelets activation6 months

Evaluation of platelets activation biomarkers by ELISA sandwich method

Evaluation of endocan levels6 months

Evaluation of values of endocan by ELISA sandwich method

Evaluation of hepcidin6 months

Evaluation of circulating levels of hepcidin by ELISA sandwich method

Determination of mammalian target of rapamycin (mTOR)6 months

Evaluation of mTOR by ELISA sandwich method

Proteomic analysis6 months

Proteomics evaluation for study of post-translational modifications of circulating protein by reference Peptides markers

Evaluation of oxidative stress6 months

Evaluation of oxidative stress biomarkers by ELISA sandwich method

Evaluation of inflammatory cytokines6 months

Evaluation of inflammatory cytokines (Interleukine-6, Interleukine-1) by ELISA sandwich method

Trial Locations

Locations (1)

University Magna Graecia Mater Domini Hospital

🇮🇹

Catanzaro, Calabria, Italy

© Copyright 2025. All Rights Reserved by MedPath